# Alnylam Pharmaceuticals Inc. – FDA Inspection, Feb 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/f171eb1e-7893-4b06-a4b1-a428da24972b
Source feed: FDA_Inspections

> FDA inspection 1262276 of Alnylam Pharmaceuticals Inc., February 25, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262276
- Company Name: Alnylam Pharmaceuticals Inc.
- Inspection Date: 2025-02-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1109687 - 2019-09-13
- [FDA Inspection 1050730 - 2018-05-04](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/1691a345-79e1-4df1-8ec0-180e5d67002c)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [Investigator](https://www.keypedia.com/people/ogechi-c-nna/59452184-8197-4ba6-bf1d-78a7e003ef2c)

Company: https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/285be436-d642-438b-ac4c-530088c678b8

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144